Prioritise cultural change to enhance pharma digital innovation efforts, says Pistoia Alliance
By Catherine Eckford (European Pharmaceutical Review)
AI in pharmaceutical development: hype or panacea?
By Dave Elder (David P Elder Consultancy)
EMA proposes streamlined approach for biosimilar development
By Catherine Eckford (European Pharmaceutical Review)
Novo Nordisk gains rights to novel small molecule inhibitor
By Catherine Eckford (European Pharmaceutical Review)
Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing
By Andy Kavanagh (MSD Ireland), John Corcoran (MSD Ireland), Oliver…
The case for immigration concessions: maintaining the UK’s competitiveness in…
By Ana Sofia Walsh (Fragomen LLP), Rajiv Naik (Fragomen LLP)